Journal of Cutaneous Immunology and Allergy, 6(6), p. 262-263, 2023
DOI: 10.1002/cia2.12333
Full text: Download
We present four Japanese patients with prurigo‐type AD who received upadacitinib. Rapid improvement of skin lesions and itchiness was seen in all patients. Janus kinase inhibitor is effective for prurigo‐type AD by strongly suppressing itching.